NCT01638598View on ClinicalTrials.gov

Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Healthy
Interventions
DRUG

matching placebo

matching placebo in each dose level

DRUG

Test drug

BI 1021958

DRUG

matching placebo

matching placebo in each dose level

DRUG

Test drug

BI 1021958

DRUG

Test drug

BI 1021958

DRUG

Test drug

BI 1021958

DRUG

Test drug

BI 1021958

DRUG

matching placebo

matching placebo in each dose level

DRUG

matching placebo

matching placebo in each dose level

DRUG

matching placebo

matching placebo in each dose level

Trial Locations (1)

Unknown

1310.3.8201 Boehringer Ingelheim Investigational Site, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01638598 - Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers | Biotech Hunter | Biotech Hunter